When a competing continuation is awarded, NIH automatically terminates the no-cost extension (if one exists), so the subcontracts have to be terminated also. -----Original Message----- From: Research Administration List [mailto:xxxxxx@hrinet.org] On Behalf Of Burnside, Sherry Sent: Wednesday, September 17, 2008 1:58 PM To: xxxxxx@hrinet.org Subject: Re: [RESADM-L] final technical reports for NIH projects under competitive renewal Folks let me describe a slightly different twist and ask a question. We have a subcontract on a project that is a continuation that has been funded early! The previous segment now has a new stop date 5 months early so funds remain. The new funds have the same grant number. We had no warning that this was about to happen. How would you handle a new subcontract to allow spending of the previous funds? THANKS ALL! -----Original Message----- From: Research Administration List [mailto:xxxxxx@hrinet.org] On Behalf Of Donahue, Sherie (LLU) Sent: Wednesday, September 17, 2008 10:50 AM To: xxxxxx@hrinet.org Subject: Re: [RESADM-L] final technical reports for NIH projects under competitive renewal In a similar situation, one of our PI's was directed by his NIH program director not to close out the project while waiting for the new grant to come through. I think that it has something to do with how many years of continuous funding and how that looks to reviewers. Sherie Donahue, MS Office of the Vice Chancellor for Research Affairs Loma Linda University Loma Linda, CA 92350 909/558-3928 or 909/558-1000, x83911 909/558-0244 (fax) -----Original Message----- From: Research Administration List [mailto:xxxxxx@hrinet.org] On Behalf Of Aull, Robert Matthew Sent: Wednesday, September 17, 2008 8:06 AM To: xxxxxx@hrinet.org Subject: Re: [RESADM-L] final technical reports for NIH projects under competitive renewal Zoya, My experience has been that NIH requires that projects remain open in order to be competitively renewed, hence the need for a no-cost extension while the competing proposal is being reviewed. A truly final technical report and/or grant closeout would not be appropriate so long the investigator has a pending application with the same grant number (through the -A2 designation). Robert Aull Indiana University School of Medicine -----Original Message----- From: Research Administration List [mailto:xxxxxx@hrinet.org] On Behalf Of Zoya Hamilton Sent: Wednesday, September 17, 2008 10:36 AM To: xxxxxx@hrinet.org Subject: [RESADM-L] final technical reports for NIH projects under competitive renewal Colleagues, Do you agree that final technical reports should be submitted for the NIH grants that ended before the application for a competitive renewal has been reviewed? I cannot think of a reason how submitting a final progress report can be detrimental to the project's likelihood to be funded in the new cycle. Has anyone experienced any problems with closing grants and then getting a renewal funded? I am asking because some PIs are not comfortable with the idea of closing their grants while they are hoping that their competitive renewal to be funded. Thanks so much for your inputs. Zoya -- Zoya Hamilton, CRA Sr. Associate Director, Research Administration Office of the Vice Provost Tufts University Tel (617) 636-6709 Fax (617) 636-2917 http://www.tufts.edu/central/ ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ====================================================================== ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ====================================================================== ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ====================================================================== The information contained in this message and any attachments is intended only for the use of the individual or entity to which it is addressed, and may contain information that is PRIVILEGED, CONFIDENTIAL, and exempt from disclosure under applicable law. If you are not the intended recipient, you are prohibited from copying, distributing, or using the information. Please contact the sender immediately by return e-mail and delete the original message from your system. ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ====================================================================== This transmission may be confidential or protected from disclosure and is only for review and use by the intended recipient. Access by anyone else is unauthorized. Any unauthorized reader is hereby notified that any review, use, dissemination, disclosure or copying of this information, or any act or omission taken in reliance on it, is prohibited and may be unlawful. If you received this transmission in error, please notify the sender immediately. Thank you. ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ======================================================================
